Webinar | Roadmap to Market for Cell and Gene Therapies
October 12, 2020
View the On-Demand Webinar
Nothing is standard about the study design, study conduct or the regulatory process in cell and gene therapy trials. Every cell and gene therapy is different due to the specific characteristics of each product, with a complicated regulatory approval process and unique therapeutic challenges.
Webinar | Reducing Study Build Time from Weeks to Days
October 1, 2020
View Webinar On-Demand
Study start-up and post-go-live protocol amendments can be lengthy, costly, and disruptive to a clinical trial. But with the right technology, data managers can accelerate timelines and overcome these challenges.
Cell and Gene Meeting On The Mesa
August 3, 2020
Meet Veristat at the Virtual event taking place October 12-14, 2020.
Gene Therapy for Rare Disorders Europe
August 3, 2020
Meet Veristat at the Virtual event taking place 26-28 October 2020.
Webinar | Minimize Disruption of Your Oncology Trial
June 4, 2020
View the On-Demand Webinar
As the world begins to relax restrictions, what are the lessons learned that can catapult us into the next innovation in trial operations for good?View the On-Webinar
Submitting an Investigational New Drug (IND) application to the US FDA is a significant step in the development of a new drug or biologic product. But, are you ready?Clinical Trials Europe 2019 | Formerly PCT Europe
October 24, 2019
Veristat will be attending Clinical Trials Europe 2019, the conference formerly known as the Partnerships in Clinical Trial Europe conference, for the first time this year.